Anti-TIGD7 monoclonal antibody

Pre-made anti-TIGD7 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TIGD7/TIGD7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2770-Ab-1/ GM-Tg-hg-IP2770-Ab-2Anti-Human TIGD7 monoclonal antibodyHuman
GM-Tg-rg-IP2770-Ab-1/ GM-Tg-rg-IP2770-Ab-2Anti-Rat TIGD7 monoclonal antibodyRat
GM-Tg-mg-IP2770-Ab-1/ GM-Tg-mg-IP2770-Ab-2Anti-Mouse TIGD7 monoclonal antibodyMouse
GM-Tg-cynog-IP2770-Ab-1/ GM-Tg-cynog-IP2770-Ab-2Anti-Cynomolgus/ Rhesus macaque TIGD7 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2770-Ab-1/ GM-Tg-felg-IP2770-Ab-2Anti-Feline TIGD7 monoclonal antibodyFeline
GM-Tg-cang-IP2770-Ab-1/ GM-Tg-cang-IP2770-Ab-2Anti-Canine TIGD7 monoclonal antibodyCanine
GM-Tg-bovg-IP2770-Ab-1/ GM-Tg-bovg-IP2770-Ab-2Anti-Bovine TIGD7 monoclonal antibodyBovine
GM-Tg-equg-IP2770-Ab-1/ GM-Tg-equg-IP2770-Ab-2Anti-Equine TIGD7 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2770-Ab-1/ GM-Tg-hg-IP2770-Ab-2; GM-Tg-rg-IP2770-Ab-1/ GM-Tg-rg-IP2770-Ab-2;
GM-Tg-mg-IP2770-Ab-1/ GM-Tg-mg-IP2770-Ab-2; GM-Tg-cynog-IP2770-Ab-1/ GM-Tg-cynog-IP2770-Ab-2;
GM-Tg-felg-IP2770-Ab-1/ GM-Tg-felg-IP2770-Ab-2; GM-Tg-cang-IP2770-Ab-1/ GM-Tg-cang-IP2770-Ab-2;
GM-Tg-bovg-IP2770-Ab-1/ GM-Tg-bovg-IP2770-Ab-2; GM-Tg-equg-IP2770-Ab-1/ GM-Tg-equg-IP2770-Ab-2
Products NameAnti-TIGD7 monoclonal antibody
Formatmab
Target NameTIGD7
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TIGD7 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2770-Ag-1Recombinant multi-species TIGD7/ Sancho protein


    Target information

    Target IDGM-IP2770
    Target NameTIGD7
    Gene ID91151,100428553,101903519,102148332
    Gene Symbol and SynonymsSancho,TIGD7
    Uniprot AccessionQ6NT04
    Uniprot Entry NameTIGD7_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000140993
    Target ClassificationN/A

    The target: TIGD7, gene name: TIGD7, also named as Sancho. The protein encoded by this gene belongs to the tigger subfamily of the pogo superfamily of DNA-mediated transposons in humans. These proteins are related to DNA transposons found in fungi and nematodes, and more distantly to the Tc1 and mariner transposases. They are also very similar to the major mammalian centromere protein B. The exact function of this gene is not known. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.